Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Influenza A(H1N1)pdm09 Virus with Reduced Susceptibility to Baloxavir, Japan, 2024
Emi Takashita

, Hiroko Morita, Shiho Nagata, Seiichiro Fujisaki, Hideka Miura, Tatsuya Ikeda, Kenichi Komabayashi, Mika Sasaki, Yohei Matoba, Tomoko Takahashi, Naomi Ogawa, Katsumi Mizuta, Sueshi Ito, Noriko Kishida, Kazuya Nakamura, Masayuki Shirakura, Shinji Watanabe, and Hideki Hasegawa
Author affiliation: Author affiliations: National Institute of Infectious Diseases, Tokyo, Japan (E. Takashita, H. Morita, S. Nagata, S. Fujisaki, H. Miura, N. Kishida, K. Nakamura, M. Shirakura, S. Watanabe, H. Hasegawa); Yamagata Prefectural Institute of Public Health, Yamagata, Japan (T. Ikeda, K. Komabayashi, M. Sasaki, Y. Matoba, T. Takahashi, N. Ogawa, K. Mizuta); Ito Clinic, Yamagata (S. Ito)
Main Article
Figure 2

Figure 2. In vitro growth kinetics of the polymerase acidic I38N mutation from study of influenza A(H1N1)pdm09 virus with reduced susceptibility to baloxavir, Japan, 2024. Humanized MDCK cells were infected with the polymerase acidic I38N mutant virus (A/Yamagata/103/2024) or its corresponding wild-type virus (A/Yamagata/336/2023) at a multiplicity of infection of 0.001 focus-forming units per cell. The supernatants were harvested at the indicated times and virus was titrated by using a focus assay. Means (circles) and SDs (error bars) of 4 experiments are shown. p values were calculated by using a t-test and fitting a mixed-effects model. FFU, focus-forming units; PA, polymerase acidic.
Main Article
Page created: March 19, 2025
Page updated: April 03, 2025
Page reviewed: April 03, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.